EU antitrust regulators to rule on Novo’s Catalent buy by Dec. 6

By Foo Yun Chee and Maggie Fick BRUSSELS/LONDON (Reuters) -EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug manufacturer Catalent (NYSE:CTLT), according…